Cristina González-Echávarri

Author

Also Known As

C Gonzalez-Echavarri, C González-Echavarri, C. Gonzalez-Echavarri, C. González-Echávarri, Cristina Gonzalez-Echavarri, Cristina González-Echavarri, Cristina González-Echávarri, F J García-Sánchez

Publications

361

Citations

H-Index

Concepts

All Affiliations

BioCruces Health research Institute University of the Basque Country Hospital Universitario Central de Asturias Instituto de Investigación Biosanitaria de Granada Bellvitge University Hospital

About

Cristina González-Echávarri is an author at BioCruces Health research Institute specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	55
2	Immunology	2	2	38
3	Nephrology	1	1	24
4	Pathology	1	1	17
5	Rheumatology	1	1	14

Cristina González-Echávarri

Publications

225

Citations

H-Index

Page 1

	Year	Citations
Off-label use of rituximab for systemic lupus erythematosus in Europe Monica Rydén‐Aulin, Dimitrios T. Boumpas, Irene E. M. Bultink, Lupus Science & Medicine	2016	65
Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort Cristina González-Echávarri, Olga Capdevila, Gerard Espinosa, Lupus	2018	49
Rituximab-refractory lupus nephritis successfully treated with belimumab. Cristina González-Echávarri, Amaia Ugarte, Guillermo Ruiz‐Irastorza PubMed GlomerulonephritisRituximab-refractory Lupus NephritisAutoimmune DiseaseLupusSystemic Treatment	2016	24
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension Alfredo Castillo, Manuel López‐Meseguer, Vicent Fonollosa‐Pla, Scientific Reports	2022	19
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry Andrés González García, M. Fabregate, Luís Manzano, Seminars in Arthritis and Rheumatism Spanish Rescle RegistryCardiomyopathyHeart FailureCardiovascular DiseaseSystemic Scleroderma	2022	17
Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone Cristina González-Echávarri, Berta Pernas, A. Ugarte, Lupus ImmunologyDermatologyImmunotherapyInflammationRheumatoid Disorder	2014	14
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i) Melani Pestaña-Fernández, Manuel Rubio‐Rivas, Carles Tolosa-Vilella, Lara D. Veeken	2020	13
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies Víctor Moreno‐Torres, Daniel Martín‐Iglesias, Florencia Vivero, Seminars in Arthritis and Rheumatism	2023	13
Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century—an observational study from the Lupus-Cruces cohort Amaia Ugarte, Alazne Garcia de Bustos, Ioana Ruiz‐Arruza, Lara D. Veeken	2021	11

Page 1